OptimizeRx to Participate in Fireside Chat and One-on-One Meetings at the 32nd Annual ROTH Conference on March 15-17, 2020
05 März 2020 - 2:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies and payers, has been
invited to present at the 32nd Annual ROTH Conference being held at
The Ritz Carlton, Laguna Niguel in Orange County, California, on
March 15-17, 2020.
The conference will feature presentations from public and
private companies across a variety of industry sectors. Last year,
the ROTH Conference hosted close to 550 participating companies and
more than 5,100 attendees, including institutional investors,
analysts, family offices and high net worth investors.
OptimizeRx CEO, Will Febbo, is scheduled to present in
one-on-one meetings with institutional analysts and investors held
at the conference. He is also scheduled to participate in a
fireside chat at 8:00 a.m. Pacific time on Tuesday, March 17. The
fireside chat will be hosted by ROTH managing director and senior
analyst, Richard K. Baldry, CFA.
Febbo will discuss a number of topics, including the company’s
newly integrated digital heath platform that allows OptimizeRx to
expand within existing clients and address the needs of larger
enterprises. This has been reflected in an increased pipeline deal
size from $130,000 in 2018 to more than $300,000 coming into 2020,
and which involves an increasing portion of recurring SaaS revenue.
He will also discuss how the company’s newly expanded commercial
team is expected to drive another year of record growth and market
expansion.
ROTH will host a pre-recorded webcast of the company’s
presentation, which will be available on the conference website
here and in the investor section of the company’s website under
“Event Calendar,” before the start of the conference.
To schedule a one-on-one meeting with OptimizeRx, please contact
your ROTH representative. For any questions about the company,
contact Ron Both of CMA at (949) 432-7557 or submit your request
here.
About Roth Capital PartnersROTH Capital
Partners, LLC (ROTH), is a relationship-driven investment bank
focused on serving emerging growth companies and their investors.
As a full-service investment bank, ROTH provides capital raising,
M&A advisory, analytical research, trading, market-making
services and corporate access. Headquartered in Newport Beach, CA,
ROTH is privately-held and employee owned, and maintains offices
throughout the U.S. For more information on ROTH, please
visit www.roth.com.
About OptimizeRxOptimizeRx® (NASDAQ: OPRX), a
digital health company, connects pharmaceutical companies to
patients and providers, offering greater affordability, adherence
and brand awareness at the point-of-care. As the nation’s largest
digital platform connecting life sciences to the point-of-care,
OptimizeRx provides a direct channel for pharma companies, payers,
medtech, and medical associations to communicate with healthcare
providers right within their workflow and also directly to
patients.
The cloud-based solution supports patient adherence to
medications and better healthcare outcomes with real-time access to
financial assistance, prior authorization, education and critical
clinical information. OptimizeRx provides more than half of the
ambulatory patient market with access to these benefits through
leading EHR platforms like Allscripts, Amazing Charts and Quest,
and directly via its mobile communications platform and digital
therapeutics SaaS platform.
For more information, follow the company on Twitter, LinkedIn or
visit www.OptimizeRx.com.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
OptimizeRx ContactDoug Baker, CFOTel (248)
651-6568 x807dbaker@optimizerx.com
Media Relations ContactMaira Alejandra, Media
Relations ManagerTel (754) 245-7070investors@optimizerx.com
Investor Relations ContactRon Both, CMATel
(949) 432-7557oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024